Health technology assessment - Joint clinical assessments of medicinal products | European Commission https://t.co/6udkS43ynW #hta #healthtechnologyassessment #healthtech #EMA

We're excited to announce that we have joined our RTI Health Solutions colleagues under the RTI Health Solutions brand. Offering our clients a complete perspective from all healthcare stakeholders, our unity reflects RTI’s unwavering commitment to improving the human condition.

If you are attending #ICPE23, visit us at booth #1000, chat with our researchers, and scan your badge to be entered to win one of three copies of Modern Epidemiology: 4th Edition, coauthored by RTI Health Solutions expert Kenneth Rothman.

Did you know ISPOR has year-round educational learning opportunities? From our conferences to webinars, summits, short courses, roundtables, and more, there is a learning format for everyone. View our upcoming events and ramp up your #HEOR knowledge! https://t.co/ktlTq1tZqC

We're attending! And here's what we'll be bringing -

Medtech companies - looking for budget-friendly value assessment & evidence gap analysis? RTI-HS is a certified NICE META tool™ facilitator. Let's see if this tool is right for your product. https://t.co/S1N0wWEYkZ #digitalhealth

Looking for a team with proven performance, adherence to ISPOR and WHO best practices, and a wide range of experience to assist you with #infectiousdisease modeling? Take a look at our qualifications.

See research on how ICER'S evidence ratings are determined. https://t.co/AznBJZdMRk #healthcare #research #costeffectiveness

RTI is proud to have earned the 2023 Military Friendly® Employer designation. https://t.co/ByOifOo3HA #diversity #inclusion

Cigna has selected RTI for their 2023 silver level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and well-being of its employees. https://t.co/0Ia3FmgF0o #EPIjobs

-How HRQOL data analysis pooled across multiple trials demonstrated extended time to deterioration in quality of life for oncology product. Read the case study-> https://t.co/uOpYg67UZT #biostatistics

Challenged with developing pre-approval information exchange (PIE) materials? We can help you communicate key pre-approval information about your medtech or #drugdevelopment. https://t.co/o95M7tszvd #GVD

We can help you identify potential gaps in your evidence and create a plan to address them—saving you time and costly re-work down the road.  https://t.co/Wwblye9zlI #pharma #CRO #drugresearch

Have you seen our case study on determining the long-term benefits of a therapy slowing kidney function decline without long-term clinical trials? Read it here-> https://t.co/jijPfoELfY #kidneyresearch #kidneyfunction

Our experts will be participating in two forums at #DIA2023: Post-Market Pregnancy Requirements, and Assessing Safety in Rare Disease and #GeneTherapy. Learn more https://t.co/0kCNjxwQ2H @DrugInfoAssn #RWD #RWE #pharma

Our approach to providing analysis results in a consistent format across trials allows clients to easily incorporate results in reports, submissions, and publications. https://t.co/KfqGjcigqB #HTA #pharmaceutical

Our experts will be participating in two forums at #DIA2023: Post-Market Pregnancy Requirements, and Assessing Safety in #RareDisease and Gene Therapy. Learn more https://t.co/0kCNjxwQ2H @DrugInfoAssn #biotech @pregnancyresearch

Research we've coauthored, Preferences for oral antipsychotic treatments: survey of patients living with bipolar I disorder, will be presented at #ISBD2023. https://t.co/3cM2PLCKMs @ISBD4

Research we've coauthored, Preferences for oral #antipsychotic treatments: survey of patients living with bipolar I disorder, will be presented at #ISBD2023. https://t.co/3cM2PLCKMs @ISBD4 #BipolarResearch

🏳‍🌈 This month, RTI is honoring #Pride2023 by celebrating our Pride Employee Resource Group (ERG). Join us as we listen to our members sharing their experiences at RTI & discussing their motivations for joining. Part 2 we spoke with Public Health Analyst, Maggie Rothenberg👇